SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-117939
Filing Date
2024-04-26
Accepted
2024-04-26 16:00:50
Documents
14
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d631189ddef14a.htm DEF 14A 397443
2 GRAPHIC g631189dsp042a.jpg GRAPHIC 86045
3 GRAPHIC g631189dsp42.jpg GRAPHIC 5062
4 GRAPHIC g631189dsp42c.jpg GRAPHIC 3741
5 GRAPHIC g631189dsp42d.jpg GRAPHIC 3092
6 GRAPHIC g631189dsp42e.jpg GRAPHIC 3001
7 GRAPHIC g631189dsp42f.jpg GRAPHIC 3724
8 GRAPHIC g631189dsp43.jpg GRAPHIC 4975
9 GRAPHIC g631189dsp43b.jpg GRAPHIC 1456
10 GRAPHIC g631189g01a16.jpg GRAPHIC 50293
11 GRAPHIC g631189g01b16.jpg GRAPHIC 47523
12 GRAPHIC g631189g01c16.jpg GRAPHIC 45402
13 GRAPHIC g631189g02a02.jpg GRAPHIC 589697
14 GRAPHIC g631189g02b02.jpg GRAPHIC 24569
  Complete submission text file 0001193125-24-117939.txt   1584164
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39692 | Film No.: 24883361
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)